Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
429.30    0.30 (0.07%)
Bid:
428.60
Ask:
428.90
Spread: 0.30 (0.07%)
Market Cap: £10.80b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

3rd Quarter Trading Update

17 Oct 2019 07:00

RNS Number : 1461Q
Rentokil Initial PLC
17 October 2019
Β 

Β Β 

17 October 2019

RENTOKIL INITIAL PLC - THIRD QUARTER TRADING UPDATE

Β 

Another strong quarter: Ongoing Organic Revenue growth of 5.5% our highest level in over 10 years, continued progress in M&A, on track to meet expectations for the full year

Β 

Β 

(Β£m)

Q3 2019

Growth

AER

AER

CER

Ongoing Revenue1

723.0

13.6%

9.8%

Revenue

727.2

13.4%

9.6%

Β 

Overview (CER)

Β 

Ongoing Revenue increased by 9.8% in Q3, of which 5.5% was Organic2 (H1 2019: 4.2%, Q3 2018: 4.1%) and 4.3% was from acquisitions.

Ongoing revenue in Pest Control grew by 12.3% (5.9% Organic), with good performances delivered across both Growth and Emerging markets, which grew by 12.2% and 12.7% respectively. Our North American, UK & Rest of World and Latin American operations delivered particularly good growth in the period.

Our Hygiene business performed well during the quarter, with Ongoing Revenue increasing by 5.5%, and Organic Revenue rising by 4.8%. This reflects good growth in the UK, Europe and Pacific and the ongoing contribution from acquisitions.

Ongoing Revenue in our Protect & Enhance category grew by 4.9% (4.5% Organic), reflecting a solid performance from both France Workwear and Ambius, and an improved performance from our UK Property Care business which encouragingly delivered positive growth.

During the third quarter the Company undertook its biennial survey of our 40,000 colleagues around the world. 90% of our colleagues participated and the results continued to place Rentokil Initial in the global High Performance group of leading companies for both Colleague Engagement and Enablement.

M&A

​We acquired 15 businesses in the quarter across all of our regions (except Pacific), with annualised revenues of c. Β£15m. 12 Pest Control businesses were acquired, predominantly in North America and Latin America. For the year to 30 September 2019 we have acquired a total of 32 businesses (24 in Pest Control, five in Hygiene and three in Protect & Enhance) primarily in Emerging and Growth markets. Annualised revenues of the businesses acquired so far in 2019 totalled c. Β£70m in the year prior to purchase. Our M&A pipeline going into Q4 and 2020 remains strong.

Conclusion of CMA reviews

Β 

The CMA's reviews into the acquisitions of Cannon UK and MPCL (formerly Mitie Pest) concluded on 30 September following completion of the partial divestments required on each by the CMA. Integration of the retained businesses is now proceeding at pace.

​Commenting on today's announcement Andy Ransom, Chief Executive, said:

"I am pleased with our Q3 results and our Group Organic Growth of 5.5% is our highest level of quarterly Organic Growth in over a decade. Pest Control has performed well, growing organically by 5.9%, and Hygiene has demonstrated further momentum, growing organically by 4.8%. Our performance in Q3, combined with further progress in our value-creating M&A programme, means we remain on track to meet expectations for the full year.

"I am also delighted to see the excellent results of our colleague survey. We continue to deliver world-class standards of colleague engagement and enablement, and we see this in turn resulting in outstanding service for our customers and higher levels of retention. I'd like to thank all of our colleagues for their ongoing commitment and determination to be the best at what we do."

Β 

Β 

Enquiries:

Β 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

Β 

Β 

1Ongoing Revenue represents the performance of the continuing operations of the Group (including acquisitions) after removing the effect of disposed or closed businesses.

Β 

2Organic Revenue represents the growth in Ongoing Revenue excluding the effect of businesses acquired during the year. Acquired businesses are included in organic measures in the year following acquisition, and the comparative period is adjusted to include an estimated full year performance for growth calculations.

Β 

AER - actual exchange rates; CER - constant 2018 exchange rates

Β 

This announcement contains statements that are, or may be, forward-looking regarding the Group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure Guidance and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTBLBDGUUBBGCL
Date   Source Headline
23rd Sep 200512:14 pmRNSRule 8.3-Rentokil Initial PLC
23rd Sep 200511:08 amRNSRule 8.3- Rentokil Init PLC
23rd Sep 200510:48 amRNSRule 8.3- Rentokil Initial
23rd Sep 20059:27 amRNSRule 8.3-Rentokil Initial PLC
23rd Sep 20058:26 amRNSAdditional Listing
22nd Sep 20054:20 pmRNSEPT Disclosure Amendment
22nd Sep 20051:28 pmRNSEPT Disclosure
22nd Sep 200512:49 pmRNSRule 8.3-Rentokil Initial PLC
22nd Sep 200512:34 pmRNSRule 8.3- Rentokil Init PLC
22nd Sep 200511:10 amRNSRule 8.3- Rentokil Initial
21st Sep 20055:53 pmRNSEPT Disclosure - Replacement
21st Sep 20055:46 pmRNSEPT Disclosure - Replacement
21st Sep 200512:28 pmRNSRule 8.3-Rentokil Initial PLC
21st Sep 200512:22 pmRNSEPT Disclosure
21st Sep 200512:00 pmRNSRule 8.3-Rentokil Initial PLC
21st Sep 200511:55 amRNSRule 8.3- Rentokil Initial pl
21st Sep 200511:01 amRNSRule 8.3-Rentokil Initial Plc
21st Sep 200510:50 amRNSRule 8.3- Rentokil Initial
21st Sep 20058:52 amRNSEPT Disclosure
20th Sep 20054:10 pmRNSEPT Disclosure - Options
20th Sep 20053:21 pmRNSEPT Disclosure
20th Sep 200512:14 pmRNSRule 8.3-Rentokil Initial PLC
20th Sep 200512:12 pmRNSRule 8.3-Rentokil Initial PLC
20th Sep 200511:16 amRNSRule 8.3- Rentokil InitialPLC
20th Sep 20059:40 amRNSRule 8.3-Rentokil Initial PLC
19th Sep 20055:30 pmRNSEPT Disclosure - Amendment
19th Sep 20053:33 pmRNSRule 8.3-Rentokil Initial PLC
19th Sep 20052:55 pmRNSEPT Disclosure - Options
19th Sep 200512:35 pmRNSRule 8.3-Rentokil Initial PLC
19th Sep 200512:26 pmRNSEPT Disclosure
19th Sep 200511:30 amRNSRule 8.3-Rentokil Initial PLC
19th Sep 20058:00 amRNSRule 2.10 Announcement
16th Sep 200512:17 pmRNSRule 8.3-Rentokil Initial PLC
16th Sep 200512:03 pmRNSEPT Disclosure
16th Sep 200511:32 amRNSRule 8.3-Rentokil Initial Plc
16th Sep 200511:26 amRNSRule 8.3-Rentokil Initial PLC
16th Sep 200510:43 amRNSRule 8.3- (Rentokil Initial)
16th Sep 20058:00 amRNSRule 2.10 Announcement
15th Sep 20053:51 pmRNSRule 8.3-Rentokil Initial PLC
15th Sep 20053:43 pmRNSEPT Disclosure-Amendment
15th Sep 200512:34 pmRNSEPT Disclosure - Options
15th Sep 200512:26 pmRNSRule 8.3- Rentokil InitialPLC
15th Sep 200512:24 pmRNSEPT Disclosure
15th Sep 200511:55 amRNSRule 8.3-Rentokil Initial PLC
15th Sep 200511:31 amRNSRule 8.3- Rentokil Initial
15th Sep 20059:59 amRNSRule 8.3-Rentokil Initial PLC
14th Sep 20055:33 pmRNSRule 8.3-Rentokil Initial PLC
14th Sep 20053:42 pmRNSPut up or Shut up deadline
14th Sep 200512:29 pmRNSRule 8.3-Rentokil Initial PLC
14th Sep 200511:55 amRNSRule 8.3- Rentokil Initial pl

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.